HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keiichi Yamanaka Selected Research

Pathologic Constriction (Stenosis)

10/2018The Stenosis of Cerebral Arteries and Impaired Brain Glucose Uptake by Long-Lasting Inflammatory Cytokine Release from Dermatitis Is Rescued by Anti-IL-1 Therapy.
3/2003Bilateral scalp necrosis with giant cell arteritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keiichi Yamanaka Research Topics

Disease

19Psoriasis (Pustulosis Palmaris et Plantaris)
05/2024 - 04/2003
16Dermatitis
12/2023 - 08/2008
12Infections
12/2023 - 01/2012
12Inflammation (Inflammations)
07/2023 - 08/2010
11Neoplasms (Cancer)
02/2023 - 03/2005
11Atopic Dermatitis (Atopic Eczema)
02/2023 - 12/2006
6Skin Diseases (Skin Disease)
12/2023 - 01/2014
5Pyoderma Gangrenosum
11/2022 - 08/2015
5Amyloidosis
05/2022 - 01/2014
4Spotted Fever Group Rickettsiosis (Rickettsialpox)
11/2023 - 11/2018
4Autoimmune Diseases (Autoimmune Disease)
01/2019 - 09/2004
3Bullous Pemphigoid (Pemphigoid)
08/2023 - 06/2019
3Exanthema (Rash)
06/2023 - 09/2021
3Rheumatoid Arthritis
10/2022 - 01/2019
3Atrophy
06/2022 - 01/2012
3Ulcer
05/2022 - 12/2020
3Melanoma (Melanoma, Malignant)
01/2022 - 08/2010
3Disseminated Intravascular Coagulation
09/2021 - 11/2015
3Cardiovascular Diseases (Cardiovascular Disease)
09/2020 - 01/2014
3Hypersensitivity (Allergy)
01/2017 - 08/2008
2Psoriatic Arthritis
05/2024 - 05/2023
2Sepsis (Septicemia)
12/2023 - 09/2021
2Arteriosclerosis
03/2023 - 01/2014
2Septic Shock (Toxic Shock Syndrome)
11/2022 - 09/2021
2Arthritis (Polyarthritis)
09/2022 - 01/2019
2Fibrosis (Cirrhosis)
06/2022 - 10/2021
2Necrosis
01/2022 - 03/2003
2Vitiligo
01/2022 - 01/2012
2Thrombosis (Thrombus)
11/2021 - 09/2018
2Urticaria (Hives)
09/2021 - 01/2021
2Cytokine Release Syndrome
09/2021 - 08/2021
2Erythema
05/2021 - 10/2020
2Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa)
05/2021 - 09/2020
2Granuloma
04/2021 - 01/2011
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 10/2020
2Emaciation
09/2020 - 01/2014
2Heart Failure
09/2020 - 01/2018
2Connective Tissue Diseases (Connective Tissue Disease)
01/2019 - 09/2018
2Systemic Scleroderma (Systemic Sclerosis)
01/2019 - 09/2018
2Pathologic Constriction (Stenosis)
10/2018 - 03/2003
2Cardiomegaly (Heart Hypertrophy)
01/2018 - 01/2014
2Paramyxoviridae Infections (Parainfluenza)
01/2017 - 01/2013
2Pruritus (Itching)
03/2014 - 08/2008
1Elephantiasis
10/2023
1B-Cell Lymphoma (Lymphoma, B Cell)
10/2023
1Churg-Strauss Syndrome (Allergic Angiitis)
06/2023
1Otitis
06/2023
1Primary Hypertrophic Osteoarthropathy (Hypertrophic Osteoarthropathy, Primary)
05/2023
1Bacterial Infections (Bacterial Infection)
02/2023

Drug/Important Bio-Agent (IBA)

23CytokinesIBA
12/2023 - 02/2009
9Interleukin-17 (Interleukin 17)IBA
11/2023 - 07/2017
6Amyloid (Amyloid Fibrils)IBA
06/2022 - 01/2014
5AntigensIBA
09/2021 - 01/2013
4Monoclonal AntibodiesIBA
05/2024 - 08/2014
4AntibodiesIBA
11/2023 - 06/2016
4Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2022 - 01/2012
4Immunoglobulin G (IgG)IBA
08/2022 - 06/2016
4Prednisolone (Predate)FDA LinkGeneric
03/2022 - 03/2003
3Messenger RNA (mRNA)IBA
03/2023 - 07/2009
3Immune Checkpoint InhibitorsIBA
01/2022 - 01/2022
3fibrin fragment D (D-dimer)IBA
11/2021 - 09/2018
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2021 - 08/2014
3InterleukinsIBA
06/2021 - 08/2014
3Interleukin-18 (Interleukin 18)IBA
08/2010 - 12/2006
2Interleukin-23 Subunit p19IBA
05/2024 - 06/2021
2guselkumabIBA
05/2024 - 10/2022
2Keratins (Keratin)IBA
12/2023 - 05/2020
2Interleukin-4 (Interleukin 4)IBA
02/2023 - 04/2013
2Anti-Bacterial Agents (Antibiotics)IBA
11/2022 - 05/2020
2Infliximab (Remicade)FDA Link
10/2022 - 01/2021
2Minocycline (Cyclops)FDA LinkGeneric
10/2022 - 08/2015
2Imiquimod (Aldara)FDA LinkGeneric
10/2022 - 05/2020
2Immunoglobulin A (IgA)IBA
08/2022 - 04/2021
2Janus Kinase InhibitorsIBA
05/2022 - 12/2021
2Therapeutic UsesIBA
05/2022 - 02/2009
2Adalimumab (Humira)FDA Link
05/2022 - 12/2020
2Prostaglandins AIBA
05/2022 - 12/2020
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2018
2Immunoglobulin E (IgE)IBA
09/2021 - 11/2018
2Interleukin-6 (Interleukin 6)IBA
08/2021 - 09/2019
2SteroidsIBA
08/2021 - 01/2012
2VaccinesIBA
04/2020 - 01/2013
2tocilizumab (atlizumab)FDA Link
09/2019 - 01/2019
2Immunoglobulins (Immunoglobulin)IBA
06/2019 - 06/2016
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2019 - 01/2012
2beta-cyclodextrin tetradecasulfate (CTDS)IBA
01/2019 - 09/2018
2EnzymesIBA
06/2016 - 08/2010
2Interleukin-12 (IL 12)IBA
08/2014 - 01/2012
2Proteins (Proteins, Gene)FDA Link
04/2013 - 07/2009
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2012 - 12/2003
2Immunosuppressive Agents (Immunosuppressants)IBA
01/2012 - 09/2004
1Toll-Like Receptor 4IBA
12/2023
1secukinumabIBA
11/2023
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2023
1AutoantibodiesIBA
08/2023
1mepolizumabIBA
06/2023

Therapy/Procedure

16Therapeutics
10/2023 - 03/2005
4Drug Therapy (Chemotherapy)
06/2023 - 01/2020
3Skin Transplantation (Skin Grafting)
11/2022 - 04/2013
3Biological Therapy
10/2022 - 08/2014